Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome, May 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 57 articles:
HTML format


 

Single Articles

  1. HEIDARI F, Afshari M, Moosazadeh M
    Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis.
    Rheumatol Int. 2017 Apr 26. doi: 10.1007/s00296-017-3725.
    Abstract    

    Abstract available

  2. MCCULLOUGH R, McCullough J
    Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop.
    Transl Gastroenterol Hepatol. 2017;2:18.
    Abstract    

    Abstract available

  3. IKECHI R, Fischer BD, DeSipio J, Phadtare S, et al
    Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management.
    Healthcare (Basel). 2017;5.
    Abstract    

    Abstract available

  4. NAGY-SZAKAL D, Williams BL, Mishra N, Che X, et al
    Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Microbiome. 2017;5:44.
    Abstract    

    Abstract available

  5. REN YJ, Zhang L, Bai T, Yu HL, et al
    Transfer of CD11c+ lamina propria mononuclear phagocytes from post-infectious irritable bowel syndrome causes mucosal barrier dysfunction and visceral hypersensitivity in recipient mice.
    Int J Mol Med. 2017 Apr 25. doi: 10.3892/ijmm.2017.2966.
    Abstract    

    Abstract available

  6. ALLEN AP, Clarke G, Cryan JF, Quigley EMM, et al
    Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms and mechanisms.
    Curr Med Res Opin. 2017 Apr 22:1-8. doi: 10.1080/03007995.2017.1322571.
    Abstract    



  7. JOHANSSON S, Rosenbaum DP, Palm J, Stefansson B, et al
    Tenapanor administration and the activity of the H+ -coupled transporter PepT1 in healthy volunteers.
    Br J Clin Pharmacol. 2017 Apr 22. doi: 10.1111/bcp.13313.
    Abstract    

    Abstract available

  8. BORTOLATO B, Kohler CA, Evangelou E, Leon-Caballero J, et al
    Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses.
    Bipolar Disord. 2017 May 3. doi: 10.1111/bdi.12490.
    Abstract    

    Abstract available

  9. MACONI G
    Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management.
    Acta Biomed. 2017;88:25-32.
    Abstract    

    Abstract available

  10. DI STEFANO M, Bergonzi M, Miceli E, Klersy C, et al
    In irritable bowel syndrome, postprandial abdominal distention is associated with a reduction of intestinal tone.
    Neurogastroenterol Motil. 2017 May 3. doi: 10.1111/nmo.13098.
    Abstract    

    Abstract available

  11. WETTSTEIN M
    [New options in the tratment of irritable bowel syndrome].
    MMW Fortschr Med. 2017;159:57-60.
    Abstract    



  12. HESSER H, Hedman E, Lindfors P, Andersson E, et al
    The specific effect of systematic exposure in irritable bowel syndrome: complier average causal effect analysis using growth mixture modeling.
    Psychol Med. 2017 May 3:1-10. doi: 10.1017/S0033291717001167.
    Abstract    

    Abstract available

  13. PORTINCASA P, Lembo A, De Bari O, Di Palo DM, et al
    The role of dietary approach in irritable bowel syndrome.
    Curr Med Chem. 2017 Apr 27. doi: 10.2174/0929867324666170428102451.
    Abstract    

    Abstract available

  14. STASI C, Bellini M, Gambaccini D, Duranti E, et al
    Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study.
    J Neurogastroenterol Motil. 2017 Apr 26. doi: 10.5056/jnm16155.
    Abstract    

    Abstract available

  15. KATSUMATA R, Shiotani A, Murao T, Ishii M, et al
    Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome.
    Intern Med. 2017;56:993-999.
    Abstract    

    Abstract available

  16. ENGELHART S, Glynn RJ, Schur PH
    Disease associations with isolated elevations of each of the four IgG subclasses.
    Semin Arthritis Rheum. 2017 Mar 30. pii: S0049-0172(16)30325.
    Abstract    

    Abstract available

  17. LABUS JS, Hollister EB, Jacobs J, Kirbach K, et al
    Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Microbiome. 2017;5:49.
    Abstract    

    Abstract available

  18. PARK BK, Chun E, Choi JJ, Shin Y, et al
    Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model.
    J Med Food. 2017 Apr 28. doi: 10.1089/jmf.2016.3844.
    Abstract    

    Abstract available

  19. CHARLESWORTH JEG, Petkovic G, Kelley JM, Hunter M, et al
    Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis.
    J Evid Based Med. 2017 Apr 27. doi: 10.1111/jebm.12251.
    Abstract    

    Abstract available

  20. CIAMPA BP, Reyes Ramos E, Borum M, Doman DB, et al
    The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders.
    Gastroenterol Hepatol (N Y). 2017;13:104-115.
    Abstract    

    Abstract available

  21. KANO M, Muratsubaki T, Morishita J, Kono K, et al
    Influence of uncertain anticipation on brain responses to aversive rectal distension in patients with irritable bowel syndrome.
    Psychosom Med. 2017 May 12. doi: 10.1097/PSY.0000000000000484.
    Abstract    

    Abstract available

  22. MADANI S, Parikh S, Madani RS, Krasaelap A, et al
    Long-Term Study of Children With ROME III Functional Gastrointestinal Disorders Managed Symptomatically in a Biopsychosocial Model.
    Gastroenterology Res. 2017;10:84-91.
    Abstract    

    Abstract available

  23. REZAPOUR M, Ali S, Stollman N
    Diverticular Disease: An Update on Pathogenesis and Management.
    Gut Liver. 2017 May 12. doi: 10.5009/gnl16552.
    Abstract    

    Abstract available

  24. SULABERIDZE G, Okujava M, Liluashvili K, Tughushi M, et al
    IMPACT OF FOOD ENRICHED WITH DIETARY FIBER ON PATIENTS WITH CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME.
    Georgian Med News. 2017;:132-135.
    Abstract    

    Abstract available

  25. JANG A, Hwang SK, Padhye NS, Meininger JC, et al
    Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial.
    J Neurogastroenterol Motil. 2017 May 8. doi: 10.5056/jnm17017.
    Abstract    

    Abstract available

  26. JUNG SE, Joo NS, Han KS, Kim KN, et al
    Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.
    J Korean Med Sci. 2017;32:948-953.
    Abstract    

    Abstract available

  27. KENWRIGHT M, McDonald J, Talbot J, Janjua K, et al
    Do Symptoms of Irritable Bowel Syndrome Improve when Patients Receive Cognitive Behavioural Therapy for Co-morbid Anxiety Disorders in a Primary Care Psychological Therapy (IAPT) Service?
    Behav Cogn Psychother. 2017 May 8:1-15. doi: 10.1017/S1352465817000200.
    Abstract    

    Abstract available

  28. SILVERMAN SL, Backonja M, Pauer L, Landen J, et al
    Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid Depression.
    Pain Med. 2017 May 19. doi: 10.1093.
    Abstract    

    Abstract available

  29. COX SR, Prince AC, Myers CE, Irving PM, et al
    Fermentable carbohydrates (FODMAPs) exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial.
    J Crohns Colitis. 2017 May 19. doi: 10.1093.
    Abstract    

    Abstract available

  30. CHAO G, Zhang S
    Aquaporins 1, 3 and 8 expression in irritable bowel syndrome rats' colon via NF-kappaB pathway.
    Oncotarget. 2017 May 2. doi: 10.18632/oncotarget.17565.
    Abstract    

    Abstract available

  31. MIZUKAMI T, Sugimoto S, Masaoka T, Suzuki H, et al
    Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome.
    Intest Res. 2017;15:236-243.
    Abstract    

    Abstract available

  32. KUMAR S, Bopanna S, Kedia S, Mouli P, et al
    Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis.
    Intest Res. 2017;15:187-194.
    Abstract    

    Abstract available

  33. ZHAO JM, Li L, Chen L, Shi Y, et al
    Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome.
    World J Gastroenterol. 2017;23:2928-2939.
    Abstract    

    Abstract available

  34. GAO M, Zhong A, Patel N, Alur C, et al
    High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases.
    World J Gastroenterol. 2017;23:2819-2825.
    Abstract    

    Abstract available

  35. JARBOL DE, Rasmussen S, Balasubramaniam K, Elnegaard S, et al
    Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study.
    BMC Gastroenterol. 2017;17:65.
    Abstract    

    Abstract available

  36. STEFFEN R
    Epidemiology of travellers' diarrhea.
    J Travel Med. 2017;24.
    Abstract    

    Abstract available

  37. KARKAR R, Schroeder J, Epstein DA, Pina LR, et al
    TummyTrials: A Feasibility Study of Using Self-Experimentation to Detect Individualized Food Triggers.
    Proc SIGCHI Conf Hum Factor Comput Syst. 2017;2017:6850-6863.
    Abstract    

    Abstract available

  38. SCHROEDER J, Hoffswell J, Chung CF, Fogarty J, et al
    Supporting Patient-Provider Collaboration to Identify Individual Triggers using Food and Symptom Journals.
    Comput Support Coop Work. 2017;2017:1726-1739.
    Abstract    

    Abstract available

  39. DEHKORDI AH, Solati K
    The effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome.
    J Adv Pharm Technol Res. 2017;8:67-72.
    Abstract    

    Abstract available

  40. GOYAL M, Goyal K, Bathla M, Kanimozhi D, et al
    Efficacy of Myofascial Unwinding and Myofascial Release Technique in a Patient with Somatic Symptoms - A Case Report.
    Indian J Psychol Med. 2017;39:199-201.
    Abstract    

    Abstract available

  41. PARFENOV AI, Akhmadullina OV, Sabelnikova EA, Belostotsky NI, et al
    [Disaccharidase deficiency and functional bowel diseases].
    Ter Arkh. 2017;89:45-52.
    Abstract    

    Abstract available

  42. YANG Q, Xu X, Zhao H, Cai Y, et al
    Differential expression of microRNAs related to irritable bowel syndrome in a rabbit model.
    J Dig Dis. 2017 May 16. doi: 10.1111/1751-2980.12485.
    Abstract    

    Abstract available

  43. ALT F, Chong PW, Teng E, Uebelhack R, et al
    Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial.
    Phytother Res. 2017 May 16. doi: 10.1002/ptr.5826.
    Abstract    

    Abstract available

  44. APPLEBY RN, Bajor A, Gillberg PG, Graffner H, et al
    Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.
    United European Gastroenterol J. 2017;5:380-388.
    Abstract    

    Abstract available

  45. LEPAGE P
    [The human gut microbiota: Interactions with the host and dysfunctions].
    Rev Mal Respir. 2017 May 12. pii: S0761-8425(17)30047.
    Abstract    

    Abstract available

  46. CHOGHAKHORI R, Abbasnezhad A, Hasanvand A, Amani R, et al
    Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: Association with digestive symptoms and quality of life.
    Cytokine. 2017 May 12. pii: S1043-4666(17)30126.
    Abstract    

    Abstract available

  47. DOSSETT ML, Cohen EM, Cohen J
    Integrative Medicine for Gastrointestinal Disease.
    Prim Care. 2017;44:265-280.
    Abstract    

    Abstract available

  48. KROGSGAARD LR, Lyngesen M, Bytzer P
    Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017 Apr 25. doi: 10.1111/apt.14065.
    Abstract    

    Abstract available

  49. MALAGELADA JR, Accarino A, Azpiroz F
    Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge.
    Am J Gastroenterol. 2017 May 16. doi: 10.1038/ajg.2017.
    Abstract    

    Abstract available

  50. REZAIE A, Park SC, Morales W, Marsh E, et al
    Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
    Dig Dis Sci. 2017 Apr 27. doi: 10.1007/s10620-017-4585.
    Abstract    

    Abstract available

  51. D'ANGELO F, Felley C, Frossard JL
    Calprotectin in Daily Practice: Where Do We Stand in 2017?
    Digestion. 2017;95:293-301.
    Abstract    

    Abstract available

  52. KEATING GM
    Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.
    Drugs. 2017 May 11. doi: 10.1007/s40265-017-0756.
    Abstract    

    Abstract available

  53. PINTO-SANCHEZ MI, Hall GB, Ghajar K, Nardelli A, et al
    Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: a Pilot Study in Patients With Irritable Bowel Syndrome.
    Gastroenterology. 2017 May 5. pii: S0016-5085(17)35557.
    Abstract    

    Abstract available

  54. NOZU T, Miyagishi S, Kumei S, Nozu R, et al
    A glucagon-like peptide-1 analog, liraglutide improves visceral sensation and gut permeability in rats.
    J Gastroenterol Hepatol. 2017 Apr 25. doi: 10.1111/jgh.13808.
    Abstract    

    Abstract available

  55. QUACH DT, Hiyama T, Nguyen TA, Ly HQ, et al
    The Asia-Pacific Colorectal Screening Score Is Useful To Stratify Risk for Colorectal Advanced Neoplasms in Vietnamese Patients with Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 May 11. doi: 10.1111/jgh.13821.
    Abstract    

    Abstract available

  56. SHARMAN SK, Islam BN, Hou Y, Usry M, et al
    Sildenafil normalizes bowel transit in preclinical models of constipation.
    PLoS One. 2017;12:e0176673.
    Abstract    

    Abstract available

  57. WANG W, Xin H, Fang X, Dou H, et al
    Isomalto-oligosaccharides ameliorate visceral hyperalgesia with repair damage of ileal epithelial ultrastructure in rats.
    PLoS One. 2017;12:e0175276.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;